Europe active pharmaceutical ingredients (API) market was valued at $ 49.4 billion in 2022 and will grow by 6.8% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 91 tables and 76 figures, this 198-page report “Europe Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe active pharmaceutical ingredients (API) market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.
Based on Molecule, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Small Molecule APIs
• Large Molecule APIs
Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Synthetic API
o Branded Synthetic API
o Generic Synthetic API
• Biotech API
o by type
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Other Biotech APIs
o by Category
Innovative Biologic API
Generic Biosimilar API
o by Expression
Mammalian Expression
Microbial Expression
Yeast Expression
Insect Expression
Other Expression Technologies
• HPAPI
o Branded HPAPI
o Generic HPAPI
Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Captive Manufacturing
o Branded Captive API
o Generic Captive API
• Merchant Manufacturing
o by Drug Type
Branded Merchant API
Generic Merchant API
o by Drug Synthesis
Merchant Synthetic API
Merchant Biotech API
By Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Pulmonary Disorders
• Orthopedics
• Other Applications
By Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
• Branded Prescription Drugs
• Generic Prescription Drugs
• OTC Drugs
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 32
2.2 Major Growth Drivers 36
2.3 Market Restraints and Challenges 44
2.4 Emerging Opportunities and Market Trends 47
2.5 Porter’s Fiver Forces Analysis 51
3 Segmentation of Europe Market by Molecule 55
3.1 Market Overview by Molecule 55
3.2 Small Molecule APIs 57
3.3 Large Molecule APIs 58
4 Segmentation of Europe Market by Synthesis 59
4.1 Market Overview by Synthesis 59
4.2 Synthetic API 61
4.2.1 Branded Synthetic API 62
4.2.2 Generic Synthetic API 63
4.3 Biotech API 64
4.3.1 Biotech API by Drug Type 65
4.3.1.1 Monoclonal Antibodies 66
4.3.1.2 Recombinant Proteins 67
4.3.1.3 Vaccines 68
4.3.1.4 Other Biotech APIs 69
4.3.2 Biotech API by Category 70
4.3.2.1 Innovative Biologic API 71
4.3.2.2 Generic Biosimilar API 72
4.3.3 Biotech API by Expression Technology 73
4.3.3.1 Mammalian Expression 74
4.3.3.2 Microbial Expression 75
4.3.3.3 Yeast Expression 76
4.3.3.4 Insect Expression 77
4.3.3.5 Other Expression Technologies 78
4.4 HPAPI 79
4.4.1 Branded HPAPI 80
4.4.2 Generic HPAPI 81
5 Segmentation of Europe Market by Manufacturing Process 82
5.1 Market Overview by Manufacturing Process 82
5.2 Captive Manufacturing 84
5.2.1 Branded Captive API 85
5.2.2 Generic Captive API 86
5.3 Merchant Manufacturing 87
5.3.1 Merchant Manufacturing by Drug Type 88
5.3.1.1 Branded Merchant API 89
5.3.1.2 Generic Merchant API 90
5.3.2 Merchant Manufacturing by Drug Synthesis 91
5.3.2.1 Merchant Synthetic API 92
5.3.2.2 Merchant Biotech API 93
6 Segmentation of Europe Market by Therapeutic Application 94
6.1 Market Overview by Therapeutic Application 94
6.2 Infectious Diseases 96
6.3 Oncology 97
6.4 Ophthalmology 98
6.5 Cardiovascular Disorders 99
6.6 Central Nervous System 100
6.7 Pulmonary Disorders 101
6.8 Orthopedics 102
6.9 Other Applications 103
7 Segmentation of Europe Market by Drug Type 104
7.1 Market Overview by Drug Type 104
7.2 Branded Prescription Drugs 106
7.3 Generic Prescription Drugs 107
7.4 OTC Drugs 108
8 European Market 2022-2032 by Country 109
8.1 Overview of European Market 109
8.2 UK 112
8.3 France 114
8.4 Germany 116
8.5 Spain 119
8.6 Italy 121
8.7 Russia 123
8.8 Rest of European Market 125
9 Competitive Landscape 127
9.1 Overview of Key Vendors 127
9.2 New Product Launch, Partnership, Investment, and M&A 130
9.3 Company Profiles 131
AbbVie Inc. 131
Astrazeneca 133
Aurobindo Pharma Ltd. 138
BASF 141
Bayer AG 144
Boehringer Ingelheim 148
Catalent Inc. 153
Dr. Reddy's Laboratories 156
F. Hoffmann-La Roche 158
GlaxoSmithKline plc 161
Lonza Group 166
Lupin Limited 170
Merck & Co., Inc. 173
Mylan NV 176
Novartis International AG 179
Pfizer Inc. 182
Sanofi 187
Sun Pharmaceutical Industries Ltd. 190
Teva Pharmaceutical Industries Ltd. 193
Thermo Fisher Scientific 195
Related Reports and Products 198
List of Tables:
Table 1. Snapshot of Europe Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 33
Table 5. World Health Spending by Region, $ bn, 2013-2020 42
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 43
Table 7. Main Product Trends and Market Opportunities in Europe Active Pharmaceutical Ingredients (API) Market 47
Table 8. Europe Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn 55
Table 9. Europe Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 59
Table 10. Europe Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn 61
Table 11. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn 65
Table 12. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn 70
Table 13. Europe Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn 73
Table 14. Europe Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn 79
Table 15. Europe Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 82
Table 16. Europe Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn 84
Table 17. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn 88
Table 18. Europe Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn 91
Table 19. Europe Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 94
Table 20. Europe Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn 104
Table 21. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn 111
Table 22. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 113
Table 23. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 113
Table 24. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 113
Table 25. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 115
Table 26. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 115
Table 27. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 115
Table 28. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 117
Table 29. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 117
Table 30. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 117
Table 31. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 120
Table 32. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 120
Table 33. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 120
Table 34. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 122
Table 35. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 122
Table 36. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 122
Table 37. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn 124
Table 38. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn 124
Table 39. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn 124
Table 40. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn 126
Table 41. AbbVie Inc.: Company Snapshot 131
Table 42. AbbVie Inc.: Business Segmentation 132
Table 43. AbbVie Inc.: Product Portfolio 132
Table 44. Astrazeneca: Company Snapshot 133
Table 45. Aurobindo Pharma Ltd.: Company Snapshot 138
Table 46. Aurobindo Pharma Ltd.: Product Portfolio 139
Table 47. BASF: Company Snapshot 141
Table 48. BASF: Business Segmentation 142
Table 49. Bayer AG: Company Snapshot 144
Table 50. Bayer AG: Business Segmentation 145
Table 51. Bayer AG: Product Portfolio 145
Table 52. Boehringer Ingelheim: Company Snapshot 148
Table 53. Boehringer Ingelheim: Product Portfolio 149
Table 54. Catalent Inc.: Company Snapshot 153
Table 55. Catalent Inc.: Business Segmentation 154
Table 56. Catalent Inc.: Product Portfolio 154
Table 57. Dr. Reddy's Laboratories: Company Snapshot 156
Table 58. Dr. Reddy's Laboratories: Business Segmentation 156
Table 59. F. Hoffmann-La Roche: Company Snapshot 158
Table 60. F. Hoffmann-La Roche: Clinical Trial Service 158
Table 61. F. Hoffmann-La Roche: Business Segmentation 159
Table 62. F. Hoffmann-La Roche: Revenue by Region 159
Table 63. GlaxoSmithKline: Company Snapshot 161
Table 64. GlaxoSmithKline: Business Segmentation 162
Table 65. GlaxoSmithKline: Product Portfolio 163
Table 66. Lonza Group: Company Snapshot 166
Table 67. Lonza Group: Business Segmentation 167
Table 68. Lonza Group: Product Portfolio 167
Table 69. Lupin Limited: Company Snapshot 170
Table 70. Lupin Limited: Business Segmentation 171
Table 71. Merck & Co., Inc.: Company Snapshot 173
Table 72. Merck & Co., Inc.: Business Segmentation 174
Table 73. Mylan NV: Company Snapshot 176
Table 74. Mylan NV: Breakdown of Revenue by Region, 2022 177
Table 75. Mylan NV: Breakdown of Revenue by Product Category, 2022 177
Table 76. Novartis International AG: Company Snapshot 179
Table 77. Novartis International AG: Business Segmentation 180
Table 78. Pfizer Inc.: Company Snapshot 182
Table 79. Pfizer Inc.: Business Segmentation 183
Table 80. Pfizer Inc.: Breakdown of Revenue by Product Category 183
Table 81. Pfizer Inc.: Breakdown of Revenue by Region 184
Table 82. Pfizer Inc.: Product Portfolio 184
Table 83. Sanofi: Company Snapshot 187
Table 84. Sanofi: Business Segmentation 188
Table 85. Sanofi: Breakdown of Revenue by Region 188
Table 86. Sun Pharmaceutical Industries Limited: Company Snapshot 190
Table 87. Teva Pharmaceutical Industries Ltd.: Company Snapshot 193
Table 88. Teva Pharmaceutical Industries Ltd.: Business Segmentation 194
Table 89. Thermo Fisher Scientific: Company Snapshot 195
Table 90. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, % 196
Table 91. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, % 196
